Han Gao Selected Research

Neoplasm Metastasis (Metastasis)

1/2022	miR-17-5p/HOXA7 Is a Potential Driver for Brain Metastasis of Lung Adenocarcinoma Related to Ferroptosis Revealed by Bioinformatic Analysis.
3/2021	The interplay between IQGAP1 and small GTPases in cancer metastasis.
1/2021	Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.
11/2017	miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han Gao Research Topics

Disease

22	Neoplasms (Cancer) 05/2022 - 01/2014
12	Inflammation (Inflammations) 01/2022 - 08/2011
10	Infections 01/2022 - 05/2014
6	Malaria 07/2021 - 12/2017
5	Hypoxia (Hypoxemia) 03/2022 - 01/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2017
4	Colitis 01/2022 - 01/2021
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
4	Carcinogenesis 12/2021 - 01/2018
4	Carcinoma (Carcinomatosis) 06/2021 - 05/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2022
3	Keratitis 01/2022 - 01/2020
3	Body Weight (Weight, Body) 01/2022 - 01/2021
3	Fatigue 01/2022 - 02/2018
3	Ulcerative Colitis 01/2022 - 01/2020
3	Metabolic Diseases (Metabolic Disease) 11/2021 - 01/2019
3	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2017
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2020 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2009
3	Hypertrophy 01/2018 - 06/2012
2	Crohn Disease (Crohn's Disease) 08/2022 - 01/2022
2	Esophageal Squamous Cell Carcinoma 11/2021 - 01/2020
2	Rectal Neoplasms (Rectal Cancer) 03/2021 - 07/2020
2	Cataract (Cataracts) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 06/2020 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 10/2017
2	Atherosclerosis 01/2019 - 01/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 01/2017
1	Paratuberculosis (Johne's Disease) 08/2022
1	Gliosis 06/2022
1	Constipation 05/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Meningioma (Meningiomas) 04/2022
1	Cerebral Infarction 03/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2014
7	CytokinesIBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 03/2022 - 07/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2016
5	EnzymesIBA 02/2019 - 01/2009
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2020
4	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2018
3	LipidsIBA 07/2022 - 01/2019
3	Biological ProductsIBA 05/2022 - 11/2017
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2019
3	VaccinesIBA 01/2019 - 06/2013
3	AntibodiesIBA 01/2019 - 01/2009
2	Peptides (Polypeptides)IBA 08/2022 - 01/2009
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 07/2022 - 02/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 11/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 01/2018
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022 - 03/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	CateninsIBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 12/2018
2	osimertinibIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2019
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2021 - 07/2021
2	Long Noncoding RNAIBA 06/2021 - 01/2019
2	LigandsIBA 03/2021 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2017
2	artemisinin (artemisinine)IBA 01/2021 - 01/2020
2	Nitrous Oxide (Laughing Gas)IBA 01/2021 - 01/2020
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2021 - 01/2018
2	PlatinumIBA 07/2020 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 06/2020 - 02/2019
2	SurvivinIBA 01/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
2	FlavonoidsIBA 04/2017 - 07/2016
2	icariinIBA 04/2017 - 07/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2016
2	Broadly Neutralizing AntibodiesIBA 05/2014 - 06/2013
2	AntigensIBA 06/2012 - 08/2011
1	Anti-Idiotypic AntibodiesIBA 08/2022
1	Galectin 3 (LGALS3)IBA 06/2022
1	B7 AntigensIBA 05/2022
1	flavoneIBA 03/2022
1	AlkaloidsIBA 01/2022
1	IronIBA 01/2022
1	HomocysteineIBA 01/2022
1	glabridinIBA 01/2022
1	MatrinesIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	wumeiIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	ADP-ribosylation factor related proteinsIBA 01/2022

Therapy/Procedure

12	Therapeutics 03/2022 - 07/2013
2	Neoadjuvant Therapy 03/2021 - 07/2020
2	Intraocular Lenses (Intraocular Lens) 01/2021 - 01/2021
2	Transplantation 10/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 07/2020 - 01/2020
1	Operative Surgical Procedures 04/2022
1	Treatment Delay 01/2022